Cardiac and renal hemodynamic effects of the antifibrinolytic agent, epsilon aminocaproic acid.
D000614:Aminocaproates / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects*; D002986:Clinical Trials as Topic; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects*
D000614:Aminocaproates